31Raaijmakers MH (2014) Disease progression in myelodysplastic syndromes: do mesenchymal
cells pave the way? Cell Stem Cell 14:695–697
Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA et al (2010) Bone
progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464:852–857
Redondo-Muñoz J, Ugarte-Berzal E, García-Marco JA, del Cerro MH, Van den Steen PE,
Opdenakker G et al (2008) Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface
docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood
112:169–178
Rombouts EJ, Pavic B, Löwenberg B, Ploemacher RE (2004) Relation between CXCR-4 expres-
sion, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood
104:550–557
Rupec RA, Jundt F, Rebholz B, Eckelt B, Weindl G, Herzinger T et al (2005) Stroma-mediated
dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity 22:479–491
Sackstein R (2011) The biology of CD44 and HCELL in hematopoiesis: the ‘step 2-bypass path-
way’ and other emerging perspectives. Curr Opin Hematol 18:239–248
Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B et al (2010)
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis
induction. J Clin Invest 120:142–156
Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O et al (2010) Incidence of
hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE
project. Blood 116:3724–3734
Seton-Rogers S (2013) Tumour microenvironment: Destroying leukaemia stem cell habitats. Nat
Rev Cancer 13:821
Shiozawa Y, Taichman RS (2010) Dysfunctional niches as a root of hematopoietic malignancy.
Cell Stem Cell 6:399–400
Sison EA, McIntyre E, Magoon D, Brown P (2013) Dynamic chemotherapy-induced upregulation
of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML. Mol Cancer
Res 11:1004–1016
Skrtić M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z et al (2011) Inhibition of mito-
chondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell
20:674–688
Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O (2001) Endothelial cell activation
by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood
97:2121–2129
Suda T, Takubo K, Semenza GL (2011) Metabolic regulation of hematopoietic stem cells in the
hypoxic niche. Cell Stem Cell 9:298–310
Sugiyama T, Kohara H, Noda M, Nagasawa T (2006) Maintenance of the hematopoietic stem cell
pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity
25:977–988
Suzuki H, Forrest AR, van Nimwegen E, Daub CO, Balwierz PJ, Irvine KM et al (2009) The
transcriptional network that controls growth arrest and differentiation in a human myeloid leu-
kemia cell line. Nat Genet 41:553–562
Tabe Y, Konopleva M (2014) Advances in understanding the leukaemia microenvironment. Br
J Haematol 164:767–778
Tabe Y, Jin L, Iwabuchi K, Wang RY, Ichikawa N, Miida T et al (2012) Role of stromal microenvi-
ronment in nonpharmacological resistance of CML to. Leukemia 26:883–892
Tabe Y, Shi YX, Zeng Z, Jin L, Shikami M, Hatanaka Y et al (2013) TGF-β-Neutralizing
Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow
Microenvironment. PLoS One 8:e62785
Tabe Y, Yamamoto S, Saitoh K, Sekihara K, Monma N, Ikeo K et al (2017) Bone Marrow
Adipocytes Facilitate Fatty Acid Oxidation Activating AMPK and a Transcriptional Network
Supporting Survival of Acute Monocytic Leukemia Cells. Cancer Res 77:1453–1464
3 Leukemia Stem Cells Microenvironment